BIOMAT Database Logo BIOMAT Database Logo

A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships. 2018

Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea.

DNA Topoisomerase IIα (topo IIα) is one of the most effective therapeutic targets to control cancer. In an effort to develop novel and effective topo IIα targeting anti-proliferative agent, a phenolic series of indenopyridinone and indenopyridinol were designed and prepared using efficient multi-component one pot synthetic method. Total twenty-two synthesized compounds were assessed for topo I and IIα inhibition, and anti-proliferation in three different human cancer cell lines. Overall structure-activity relationship study explored the significance of meta-phenolic group at 4-position and para-phenolic group at 2- and/or 4-position of indenopyridinone skeleton for strong topo IIα-selective inhibition and anti-proliferative activity against human cervix (HeLa) and colorectal (HCT15) cell lines. Compound 12 with excellent topo IIα inhibition (93.7%) was confirmed as a DNA intercalator that could be a new promising lead to develop effective topo IIα-targeted anticancer agents.

UI MeSH Term Description Entries
D007192 Indenes A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
New phenolic cinnamic acid derivatives as selective COX-2 inhibitors. Design, synthesis, biological activity and structure-activity relationships.
October 2019, Bioorganic chemistry,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors.
February 2018, Bioorganic & medicinal chemistry letters,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.
August 1998, Bioorganic & medicinal chemistry letters,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.
August 2007, Bioorganic & medicinal chemistry letters,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD.
January 2006, Bioorganic & medicinal chemistry letters,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
Design, Synthesis, and Structure-Activity relationships of Evodiamine-Based topoisomerase (Top)/Histone deacetylase (HDAC) dual inhibitors.
May 2022, Bioorganic chemistry,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors.
October 2013, Journal of medicinal chemistry,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
February 2008, Bioorganic & medicinal chemistry letters,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
Study on the design, synthesis and structure-activity relationships of new thiosemicarbazone compounds as tyrosinase inhibitors.
October 2017, European journal of medicinal chemistry,
Aarajana Shrestha, and Seojeong Park, and Hae Jin Jang, and Pramila Katila, and Ritina Shrestha, and Youngjoo Kwon, and Eung-Seok Lee
Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation.
October 2005, Journal of medicinal chemistry,
Copied contents to your clipboard!